Login
← Go Back
Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024
Stock Price vs Company Growth
1d
0.8%
1w
1.0%
1m
0.6%
3m
8.5%
6m
14.6%
1y
27.7%
all
20.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 982 0.8%
786
1,082
Company Overview
Sales
2,170 Cr
Growth: 29.1%
Profit after Tax
333 Cr
Growth: 16.2%
Mid Cap
20,801 Cr
P/E: 62.9x
Industry P/E: 28.0x
Fundamentals
Sales (Cr) ₹ 2,170
Growth 29.1%
EBITDA 28.2%
P/S 9.6x
Dividend 0.0%
P/E 62.9x
Book Value ₹ 112
PEG Ratio 2.2x
ROE 14.9%
P/B 8.8x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Belongs to (28 Indices) view more
Followers (1)
varsha96